Attorneys for three women who claim they developed type 2 diabetes after taking the cholesterol-lowering drug, Lipitor, have filed a motion to consolidate all lawsuits filed against Pfizer, the manufacturer of Lipitor, in a South Carolina federal court. The consolidation of these lawsuits, commonly referred to as multidistrict litigation (MDL), allows all pre-trial proceedings to be centralized before one judge. This helps to provide consistency in court rulings and a conservation of resources for all parties involved in the litigation.
The FDA issued a safety warning in February 2012 for Lipitor and other statin drugs after studies revealed thatwomen taking Lipitor have an increased risk for developing type 2 diabetes mellitus. The study specifically noted that women with a body mass index of 25 or under, considered ‘normal’ weight range per CDC standards, ran the highest risk for developing high blood sugar levels and diabetes.
Our product liability attorneys are currently speaking to women who have taken Lipitor and have developed type 2 diabetes. If you or someone you care about is a woman who has been taking Lipitor for the treatment of high cholesterol and has developed type 2 diabetes, contact us. Our product liability attorneys have litigated thousands of claims against pharmaceutical and medical device manufacturers and can advise you of your legal rights and options. Complete your free Lipitor case evaluation here.